Evidence map›Paper›PMID 24217556›Full record

ArticleThe pharmacogenomics journal2014

Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity.

J D Zhang, N Berntenis, A Roth, M Ebeling

Abstract read
In one paragraph

Article in The pharmacogenomics journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Harnessing male germline epigenomics for the genetic improvement in cattle.Journal of animal science and biotechnology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. An Introduction to Machine Learning.Clinical pharmacology and therapeutics · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Assessing Chemical-Induced Liver InjuryFrontiers in genetics · 2019
    Article
  17. Imidazo[1,2-Molecules (Basel, Switzerland) · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J D ZhangpRED Pharma Research and Development, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, Switzerland.
N BerntenispRED Pharma Research and Development, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, Switzerland.
A RothpRED Pharma Research and Development, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, Switzerland.
M EbelingpRED Pharma Research and Development, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene signatures of drug-induced toxicity are of broad interest, but they are often identified from small-scale, single-time point experiments, and are therefore of limited applicability. To address this issue, we performed multivariate analysis of gene expression, cell-based assays, and histopathological data in the TG-GATEs (Toxicogenomics Project-Genomics Assisted Toxicity Evaluation system) database. Data mining highlights four genes-EGR1, ATF3, GDF15 and FGF21-that are induced 2 h after drug administration in human and rat primary hepatocytes poised to eventually undergo cytotoxicity-induced cell death. Modelling and simulation reveals that these early stress-response genes form a functional network with evolutionarily conserved structure and intrinsic dynamics. This is underlined by the fact that early induction of this network in vivo predicts drug-induced liver and kidney pathology with high accuracy. Our findings demonstrate the value of early gene-expression signatures in predicting and understanding compound-induced toxicity. The identified network can empower first-line tests that reduce animal use and costs of safety evaluation.

Indexed as

Data MiningGene Expression ProfilingGenes, Immediate-EarlyToxicity TestsHumansIn Vitro Techniques

Identifiers

PMID24217556
PMCPMC4034126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.